Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-29 · accession 0000950170-25-011959 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-31 | 2025-01-29 | SRPT | Estepan Ian Michael | CFO | M - OptEx | $12.00 | +15.8K | 49.5K | +47% | +$189.6K |
| D | 2025-01-31 | 2025-01-29 | SRPT | Estepan Ian Michael | CFO | F - Tax | $117.51 | -2,613 | 46.9K | -5% | -$307.1K |
| DM | 2025-01-31 | 2025-01-29 | SRPT | Estepan Ian Michael | CFO | M - OptEx | $0.00 | -15.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-29 | M | A | 14,267 | $12.00 | 47,963 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-29 | M | A | 1,533 | $12.00 | 49,496 | D | — | — | |
| 3 | Common | Common Stock | 2025-01-29 | F | D | 2,613 | $117.51 | 46,883 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-01-29 | M | D | 1,533 | $0.00 | 0 | D | $12.00 · 2016-01-30 to 2025-01-30 | 1,533 Common Stock | |
| 5 | Derivative | Stock Option (right to buy) | 2025-01-29 | M | D | 14,267 | $0.00 | 0 | D | $12.00 · 2016-01-30 to 2025-01-30 | 14,267 Common Stock |